DCM

Miami International Holdings Reports Trading Results for March 2024; MIAX Pearl Equities YTD Volumes and Market Share at Record Levels

Retrieved on: 
Friday, April 5, 2024

Total year-to-date (YTD) volume reached 422.7 million contracts, a 2.6% decrease from the same period in 2023.

Key Points: 
  • Total year-to-date (YTD) volume reached 422.7 million contracts, a 2.6% decrease from the same period in 2023.
  • MIAX Options reached a monthly volume of 55.1 million contracts, a 13.9% decrease YoY and a 5.5% decrease from February 2024.
  • In U.S. equities, MIAX Pearl Equities™ reached a monthly volume of 4.5 billion shares, a 1.1% increase YoY and representing a market share of 1.87%, a 20.8% increase YoY.
  • Additional MIAX Exchange Group and MGEX trading volume and market share information are included in the tables below.

Miami International Holdings Reports Trading Results for March 2024; MIAX Pearl Equities YTD Volumes and Market Share at Record Levels

Retrieved on: 
Friday, April 5, 2024

Total year-to-date (YTD) volume reached 422.7 million contracts, a 2.6% decrease from the same period in 2023.

Key Points: 
  • Total year-to-date (YTD) volume reached 422.7 million contracts, a 2.6% decrease from the same period in 2023.
  • MIAX Options reached a monthly volume of 55.1 million contracts, a 13.9% decrease YoY and a 5.5% decrease from February 2024.
  • In U.S. equities, MIAX Pearl Equities™ reached a monthly volume of 4.5 billion shares, a 1.1% increase YoY and representing a market share of 1.87%, a 20.8% increase YoY.
  • Additional MIAX Exchange Group and MGEX trading volume and market share information are included in the tables below.

WSB Announces Partnership With 4M Analytics to Advance Infrastructure Programs & Projects

Retrieved on: 
Wednesday, March 27, 2024

WSB LLC (“WSB”), one of the nation’s fastest growing infrastructure engineering and consulting firms, today announced a partnership with 4M Analytics, the nation’s leading subsurface Utility AI Mapping and Analytics Solution.

Key Points: 
  • WSB LLC (“WSB”), one of the nation’s fastest growing infrastructure engineering and consulting firms, today announced a partnership with 4M Analytics, the nation’s leading subsurface Utility AI Mapping and Analytics Solution.
  • This partnership will immediately support infrastructure projects across the U.S. with a focus on data integrity and real-time digital delivery.
  • “4M Analytics brings much-needed nationwide improvement to utility conflict resolution, and they are doing it with cutting-edge AI and machine learning technology.
  • “WSB is an industry leader in using tools and technologies to improve the way we deliver infrastructure projects across the U.S.,” said Itzik Malka, 4M Analytics CEO.

DATA Communications Management Corp. to Announce Fiscal 2023 and Q4 2023 Results on March 19, 2024

Retrieved on: 
Thursday, March 14, 2024

DATA Communications Management Corp. (TSX: DCM; OTCQX: DCMDF) (“DCM” or the "Company"), a leading provider of marketing and business communication solutions to companies across North America, will announce its Fiscal 2023 and Q4 2023 results the evening of Tuesday, March 19, 2024.

Key Points: 
  • DATA Communications Management Corp. (TSX: DCM; OTCQX: DCMDF) (“DCM” or the "Company"), a leading provider of marketing and business communication solutions to companies across North America, will announce its Fiscal 2023 and Q4 2023 results the evening of Tuesday, March 19, 2024.
  • The Company will host a conference call and webcast on Wednesday, March 20, 2024, at 9:00 a.m. Eastern time.
  • Richard Kellam, President and CEO of DCM, and James Lorimer, CFO, will present the Fiscal 2023 and Q4 2023 results followed by a live Q&A.
  • If you’re unable to take part live, a replay of the webcast will be available on the DCM Investor Relations page under the prior events section.

Tami Erwin, former CEO of Verizon Business, joins Skylo's Board of Directors

Retrieved on: 
Tuesday, March 26, 2024

MOUNTAIN VIEW, Calif., March 26, 2024 /PRNewswire-PRWeb/ -- Skylo Technologies, the pioneer in Non-Terrestrial Networks (NTN), is excited to announce the addition of Tami Erwin to its Board of Directors. Erwin's appointment brings a wealth of carrier experience and leadership to Skylo, reinforcing the company's position as a global leader in connecting smartphone and IoT cellular devices directly over satellite. Erwin's current board roles include prestigious positions at John Deere, F5, and York Space Systems, bringing a diverse and rich perspective to Skylo's strategic direction.

Key Points: 
  • Skylo proudly announces that Tami Erwin, a distinguished figure with over three decades of leadership in telecommunications, has joined its Board of Directors.
  • MOUNTAIN VIEW, Calif., March 26, 2024 /PRNewswire-PRWeb/ -- Skylo Technologies , the pioneer in Non-Terrestrial Networks (NTN), is excited to announce the addition of Tami Erwin to its Board of Directors.
  • Tami Erwin is renowned for her transformative leadership in the telecommunications industry, notably as the former Executive Vice President and CEO of Verizon Business.
  • "We're honored to welcome Tami Erwin to our board," said Parthsarathi Trivedi, CEO and Co-Founder of Skylo Technologies.

Rocket Pharmaceuticals Reports Fourth Quarter and Full Year 2023 Financial Results and Highlights Recent Progress

Retrieved on: 
Monday, February 26, 2024

Rocket Pharmaceuticals, Inc. (NASDAQ: RCKT), a fully integrated, late-stage biotechnology company advancing a sustainable pipeline of genetic therapies for rare disorders with high unmet need, today reported financial and operational results for the fourth quarter and year ended December 31, 2023.

Key Points: 
  • Rocket Pharmaceuticals, Inc. (NASDAQ: RCKT), a fully integrated, late-stage biotechnology company advancing a sustainable pipeline of genetic therapies for rare disorders with high unmet need, today reported financial and operational results for the fourth quarter and year ended December 31, 2023.
  • “I am pleased with the strong results Rocket delivered in 2023, as we closed another successful year of progress across all six disclosed gene therapy programs spanning our AAV cardiovascular and LV hematology portfolios,” said Gaurav Shah, M.D., Chief Executive Officer, Rocket Pharma.
  • Results from the study demonstrated the potential of RP-A601 as a gene therapy for patients with PKP2-ACM.
  • As of December 31, 2023, Rocket had cash, cash equivalents and investments of $407.5 million.

Durlston Partners Welcomes Vikram Tandon to Strengthen Its Portfolio Management & Quant Recruitment Services

Retrieved on: 
Wednesday, February 21, 2024

Durlston Partners, a leading recruitment firm specializing in Technology, Quantitative Finance, Data Science, and Digital Assets, proudly announces the addition of Vikram Tandon as a seasoned consultant in financial services executive recruiting.

Key Points: 
  • Durlston Partners, a leading recruitment firm specializing in Technology, Quantitative Finance, Data Science, and Digital Assets, proudly announces the addition of Vikram Tandon as a seasoned consultant in financial services executive recruiting.
  • "Vikram's wealth of experience significantly strengthens our ability to provide exceptional talent advisory services," said Meraj Bahram, Managing Partner at Durlston Partners in London.
  • “A big thank you to Meraj and the partners for bringing me into this talented team,” said Vikram Tandon.
  • Durlston Partners is a leading recruitment firm specializing in Technology, Quantitative Finance, Data Science, and Digital Assets.

Miami International Holdings Reports Trading Results for February 2024; MIAX Exchange Group YTD Options and Equities Volumes at Record Levels while MGEX Futures Volume Surges 30.3%

Retrieved on: 
Thursday, March 7, 2024

PRINCETON, N.J., March 7, 2024 /PRNewswire/ -- Miami International Holdings, Inc. (MIH) today reported February 2024 trading results for its U.S. exchange subsidiaries – MIAX®, MIAX Pearl® and MIAX Emerald® (together, the MIAX Exchange Group), and Minneapolis Grain Exchange (MGEX™).

Key Points: 
  • PRINCETON, N.J., March 7, 2024 /PRNewswire/ -- Miami International Holdings, Inc. (MIH) today reported February 2024 trading results for its U.S. exchange subsidiaries – MIAX®, MIAX Pearl® and MIAX Emerald® (together, the MIAX Exchange Group), and Minneapolis Grain Exchange (MGEX™).
  • Total year-to-date (YTD) volume reached a record 285.8 million contracts, a 4.8% increase from the same period in 2023.
  • MIAX Options reached a monthly volume of 58.3 million contracts, a 6.3% increase YoY and a 2.6% increase from January 2024.
  • Additional MIAX Exchange Group and MGEX trading volume and market share information are included in the tables below.

Miami International Holdings Reports Trading Results for February 2024; MIAX Exchange Group YTD Options and Equities Volumes at Record Levels while MGEX Futures Volume Surges 30.3%

Retrieved on: 
Thursday, March 7, 2024

PRINCETON, N.J., March 7, 2024 /PRNewswire/ -- Miami International Holdings, Inc. (MIH) today reported February 2024 trading results for its U.S. exchange subsidiaries – MIAX®, MIAX Pearl® and MIAX Emerald® (together, the MIAX Exchange Group), and Minneapolis Grain Exchange (MGEX™).

Key Points: 
  • PRINCETON, N.J., March 7, 2024 /PRNewswire/ -- Miami International Holdings, Inc. (MIH) today reported February 2024 trading results for its U.S. exchange subsidiaries – MIAX®, MIAX Pearl® and MIAX Emerald® (together, the MIAX Exchange Group), and Minneapolis Grain Exchange (MGEX™).
  • Total year-to-date (YTD) volume reached a record 285.8 million contracts, a 4.8% increase from the same period in 2023.
  • MIAX Options reached a monthly volume of 58.3 million contracts, a 6.3% increase YoY and a 2.6% increase from January 2024.
  • Additional MIAX Exchange Group and MGEX trading volume and market share information are included in the tables below.

Journal of Pharmaceutical Analysis Articles Provide Novel Insights into Previously Unknown Disease Mechanisms

Retrieved on: 
Tuesday, February 27, 2024

XI'AN, China, Feb. 27, 2024 /PRNewswire/ -- DCM is the leading cause of heart failure in patients with chronic diabetes, with unclear mechanisms and limited treatments. Another mystery is the regulation of cytochrome P450 enzymes (CYPs) in the central nervous system. Moreover, the link between the gut microbiome, microbiota-derived metabolites, and the progression of AD remains unknown. In the December issue of Journal of Pharmaceutical Analysis (JPA), three articles explore the interconnected pathologies of DCM, hippocampal neurotoxicity, and AD, offering a comprehensive insight.

Key Points: 
  • Moreover, the link between the gut microbiome, microbiota-derived metabolites, and the progression of AD remains unknown.
  • In the December issue of Journal of Pharmaceutical Analysis (JPA), three articles explore the interconnected pathologies of DCM, hippocampal neurotoxicity, and AD, offering a comprehensive insight.
  • Their findings, available online on 17 August 2023, were published in Volume 13, Issue 12 of the journal in December 2023.
  • Gut dysbiosis aggravates cognitive deficits, amyloid pathology and lipid metabolism dysregulation in a transgenic mouse model of Alzheimer's disease